Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for SDEV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 127.24M
March 31, 2026 138.82M
September 30, 2025 1.634M
June 30, 2025 4.245M
March 31, 2025 6.167M
December 31, 2024 -0.129M
September 30, 2024 1.072M
June 30, 2024 -0.617M
March 31, 2024 0.16M
December 31, 2023 3.314M
September 30, 2023 7.037M
June 30, 2023 8.563M
March 31, 2023 8.89M
December 31, 2022 10.55M
September 30, 2022 13.78M
June 30, 2022 15.74M
March 31, 2022 17.75M
December 31, 2021 10.17M
September 30, 2021 9.364M
June 30, 2021 11.21M
March 31, 2021 10.98M
December 31, 2020 12.32M
September 30, 2020 13.88M
June 30, 2020 0.983M
March 31, 2020 -0.349M
Date Value
December 31, 2019 0.973M
September 30, 2019 2.923M
June 30, 2019 1.669M
March 31, 2019 1.129M
December 31, 2018 4.954M
September 30, 2018 6.059M
June 30, 2018 7.429M
March 31, 2018 8.871M
December 31, 2017 2.594M
September 30, 2017 1.832M
June 30, 2017 3.209M
March 31, 2017 4.356M
December 31, 2016 7.101M
September 30, 2016 6.718M
June 30, 2016 -2.467M
March 31, 2016 -7.299M
December 31, 2015 -5.098M
September 30, 2015 0.227M
June 30, 2015 4.904M
March 31, 2015 2.149M
December 31, 2014 1.848M
September 30, 2014 5.69M
June 30, 2014 9.22M
March 31, 2014 11.84M
December 31, 2013 8.516M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M
Johnson & Johnson 84.97B
Eli Lilly & Co. 33.88B

Shareholders Equity (Quarterly) Related Metrics